Publications by authors named "Boris Calmels"

Claim this Profile
S
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link.
Ugo Chartral, Jeanne Galaine, Camille Giverne, Céline Auxenfans, Loic Reppel, Boris Calmels

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)].
Justine Nasone, Carina Alves Goncalves, Caroline Ballot, Ulrick Birba, Maxime Bouabdelli, Boris Calmels

Bull Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Boris Calmels

Bone Marrow Transplant· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, Sylvain Garciaz, Thomas Pagliardini, Boris Calmels

Bone Marrow Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
François Dachy, Sabine Furst, Boris Calmels, Thomas Pagliardini, Samia Harbi

Bone Marrow Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC].
Edouard Forcade, Solenn Bacquet, Caroline Ballot, Lucille Capin, Federico Garnier, Boris Calmels

Bull Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
Bechara Mfarrej, Olivier Vicari, Sarah Ouffai, Carine Malenfant, Angela Granata, Boris Calmels

J Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.
Raynier Devillier, Boris Calmels, Sophie Guia, Mohammed Taha, Cyril Fauriat

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products.
Bechara Mfarrej, Julie Gaude, Jerome Couquiaud, Boris Calmels, Christian Chabannon

Cytotherapy· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CD34+ cell selection methods, quality controls and expected results: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Boris Calmels, Éric Gautier, Alessandra Magnani, Élisa Magrin, Anne-Claire Mamez

Bull Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF.
Sylvain Garciaz, Patrick Sfumato, Angela Granata, Anne-Marie Imbert, Claire Fournel, Boris Calmels

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.
Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, Laura Giordano, Catalina Montes de Oca, Boris Calmels

Blood Adv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation.
Charlotte Nykolyszyn, Angela Granata, Thomas Pagliardini, Luca Castagna, Samia Harbi, Boris Calmels

Bone Marrow Transplant· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.
Angela Granata, Sabine Fürst, Stefania Bramanti, Faezeh Legrand, Barbara Sarina, Boris Calmels

Bone Marrow Transplant· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Melanie Velier, Angela Granata, Stefania Bramanti, Boris Calmels, Sabine Furst

Transfusion· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.
Sylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, Christine Chevalier, Julien Vernerey, Boris Calmels

Clin Epigenetics· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Thomas Pagliardini, Lucas Castagna, Samia Harbi, Matteo Della Porta, Jerome Rey, Boris Calmels

Biol Blood Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products.
Mélanie Velier, Anne-Line Chateau, Carine Malenfant, Sarah Ouffai, Boris Calmels

Cytotherapy· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.
Thomas Pagliardini, Samia Harbi, Sabine Fürst, Luca Castagna, Faezeh Legrand, Boris Calmels

Bone Marrow Transplant· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3 cells.
Raphael Cauchois, Luca Castagna, Thomas Pagliardini, Samia Harbi, Boris Calmels

Br J Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
John De Vos, Etienne Baudoux, Jacques-Olivier Bay, Boris Calmels, Audrey Cras

Bull Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Raynier Devillier, Faezeh Legrand, Jérôme Rey, Luca Castagna, Sabine Fürst, Boris Calmels

Biol Blood Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From clinical proof-of-concept to commercialization of CAR T cells.
Boris Calmels, Bechara Mfarrej, Christian Chabannon

Drug Discov Today· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Anne Wanquet, Stephania Bramanti, Samia Harbi, Sabine Fürst, Faezeh Legrand, Boris Calmels

Biol Blood Marrow Transplant· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis